Biotinylated Human CD229 / SLAMF3 Protein, His, Avitag™, premium grade | CD9-H82E6-200ug

Biotinylated Human CD229 / SLAMF3 Protein, His, Avitag™, premium grade | CD9-H82E6-200ug| Gentaur Distribution US, UK & Europe

CD229, also known as Ly9 and SLAMF3, is a 120 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family. Signaling lymphocyte activation molecule (SLAM) family receptors are critically involved in modulating innate and adaptive immune responses. CD229 is expressed on T and B cells, thymocytes, and more weakly on NK cells. Homophilic binding between CD229 molecules is mediated by the N-terminal Ig-like domain.

Source: Biotinylated Human CD229, His, Avitag (CD9-H82E6) is expressed from human 293 cells (HEK293). It contains AA Lys 48 - Lys 454 (Accession # Q9HBG7-1).

Format: Powder.

Tag: C-10×His & C-Avi.

Expression System: HEK293.

Expression Region: Lys 48 - Lys 454.

Conjugate: Biotin-labeled.

Molecular Weight: 48.5 kDa.

Characteristics: This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™). The protein has a calculated MW of 48.5 kDa. The protein migrates as 65-80 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Purity: 95%.

Buffer: PBS, pH7.4.

Storage Conditions: -20℃.

Shipping Conditions: RT